TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 23588194

Group type: EXPERIMENTAL
Intervention: SL‐LVH
Number of subjects: 2993

Group type: EXPERIMENTAL
Intervention: CV‐LVH
Number of subjects: 2993

Group type: EXPERIMENTAL
Intervention: CP‐LVH
Number of subjects: 2993

Group type: EXPERIMENTAL
Intervention: SBP
Number of subjects: 2993

Group type: EXPERIMENTAL
Intervention: CV‐LVH and CP‐LVH
Number of subjects: 2993

Group type: EXPERIMENTAL
Intervention: SL‐ECG
Number of subjects: 2993
Study: 21311365

Group type: EXPERIMENTAL
Intervention: Creatine (CR) supplementation (20 g·d(‐1) for 1 week and 5 g·d(‐1) thereafter)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Creatine (CR) supplementation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Both CR and PL groups
Number of subjects: 0
Study: 19272165

Group type: EXPERIMENTAL
Intervention: Phone group
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Visit group
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study: 17604500

Group type: EXPERIMENTAL
Intervention: Somatostatin analogs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Systemic agents such as IFN‐alpha or cytotoxic chemotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Streptozocin-based therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Radiolabeled somatostatin analogs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Agents targeting the VEGF pathway and mammalian target of rapamycin
Number of subjects: 0
Study: 15366593

Group type: EXPERIMENTAL
Intervention: Tongluo capsule (TLC)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Control group (WM group)
Number of subjects: 97
Study: 11576034

Group type: EXPERIMENTAL
Intervention: Tyrosine transport in fibroblasts from patients with schizophrenia
Number of subjects: 46

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 46
Study: 9563981

Group type: EXPERIMENTAL
Intervention: Intravenous streptokinase (1.5 MU in 1 hour)
Number of subjects: 17187

Group type: EXPERIMENTAL
Intervention: Oral aspirin (162 mg daily for 1 month)
Number of subjects: 17187

Group type: EXPERIMENTAL
Intervention: Combination of streptokinase and one month of aspirin
Number of subjects: 17187

Group type: COMPARATOR
Intervention: Matching placebos
Number of subjects: 17187
Study: 7981002

Group type: EXPERIMENTAL
Intervention: Serum copper (Cu) and serum copper/zinc ratio (Cu/Zn) in lung cancer patients (LC)
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Serum zinc (Zn) in lung cancer patients (LC)
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Serum copper (Cu) and serum copper/zinc ratio (Cu/Zn)
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Higher Cu and Cu/Zn levels
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Receiver operator characteristic (ROC) curve for Cu, Cu/Zn, and carcinoembryonic antigen (CEA)
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Determinations of Cu, Zn, and Cu/Zn
Number of subjects: 162
Study: 2589003

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Low dose
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: High dose
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Letter cancellation test
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Critical flicker fusion
Number of subjects: 26
Study: 1093559

Group type: EXPERIMENTAL
Intervention: Quinidine (Kinidin Durules)
Number of subjects: 176

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 176
Study: 31526791

Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle training by a physical therapist (12 weekly sessions starting at ∼9 weeks postpartum)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Control group (no instructions after initial assessment)
Number of subjects: 84
Study: 31077065

Group type: EXPERIMENTAL
Intervention: Diclofenac sodium 75 mg/1 mL solution administered as a 5-s intravenous bolus
Number of subjects: 0
Study: 30021506

Group type: EXPERIMENTAL
Intervention: Telephone-delivered intervention incorporating behavioral activation
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Collaborative care framework
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: CASPER plus model
Number of subjects: 33
Study: 26753501

Group type: EXPERIMENTAL
Intervention: Postero-medial tendon harvesting (group 1)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conventional antero-medial tendon harvesting (group 2)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 100
Study: 24519331

Group type: EXPERIMENTAL
Intervention: Mental practice group received 1 × 60‐min, followed by 3 × 30‐min sessions of supervised mental practice and 15 min/day of self‐guided imagery sessions.
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group did no training.
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Both groups (Mental practice and Control)
Number of subjects: 18
Study: 23158705

Group type: EXPERIMENTAL
Intervention: Aromatherapy massage with lavender oil
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo massage with odorless liquid petrolatum
Number of subjects: 150
Study: 20179657

Group type: EXPERIMENTAL
Intervention: Skin-to-skin contact (SSC)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Routine care (control)
Number of subjects: 34
Study: 18055296

Group type: EXPERIMENTAL
Intervention: Lightwand-guided endotracheal intubation with right hand (group R; n = 80)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Lightwand-guided endotracheal intubation with left hand (group L; n = 80)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Direct-vision laryngoscope (group D; n = 80)
Number of subjects: 240
Study: 16086927

Group type: EXPERIMENTAL
Intervention: Omapatrilat (40 mg every day)
Number of subjects: 321

Group type: COMPARATOR
Intervention: Enalapril (10 mg twice a day)
Number of subjects: 321
Study: 12163792

Group type: EXPERIMENTAL
Intervention: Serum procalcitonin
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Cerebrospinal fluid cell count
Number of subjects: 34
Study: 10473964

Group type: EXPERIMENTAL
Intervention: Topical retinaldehyde (RAL)
Number of subjects: 45
Study: 7663811

Group type: EXPERIMENTAL
Intervention: Severe ARDS diagnosed in ICU patients (oxygenation criterion: PaO2/PAO2 < or = 0.2)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Estimation of undetected ARDS cases
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Estimation of ARDS incidence
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Estimation of lower limit for ARDS incidence
Number of subjects: 110
Study: 2257858

Group type: EXPERIMENTAL
Intervention: Nifedipine 5 mg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Nifedipine 10 mg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Nicardipine 20 mg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Nicardipine 30 mg
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 7396165

Group type: EXPERIMENTAL
Intervention: Carticaine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Mepivacaine
Number of subjects: 0
Study: 31678749

Group type: EXPERIMENTAL
Intervention: Outdoor Cycling (OC)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Occupational Therapy (OT)
Number of subjects: 60
Study: 31464895

Group type: EXPERIMENTAL
Intervention: Fermented milk containing Lactobacillus paracasei HP7 and Glycyrrhiza glabra, administered once daily for 8 weeks
Number of subjects: 142

Group type: COMPARATOR
Intervention: Placebo (fermented milk only), administered once daily for 8 weeks
Number of subjects: 142
Study: 28363354

Group type: EXPERIMENTAL
Intervention: NOACs
Number of subjects: 344

Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 344
Study: 25927622

Group type: EXPERIMENTAL
Intervention: Baclofen treatment (up to 60 mg/day)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 80
Study: 23992649

Group type: EXPERIMENTAL
Intervention: 600 mg benfotiamine once daily for 24 weeks
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo once daily for 24 weeks
Number of subjects: 120
Study: 21558141

Group type: EXPERIMENTAL
Intervention: i.v. ghrelin (5 pmol/kg per min)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 26
Study: 19852122

Group type: EXPERIMENTAL
Intervention: 0.1% retinol facial moisturizer
Number of subjects: 64

Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 64
Study: 17717250

Group type: EXPERIMENTAL
Intervention: Femoral nerve block
Number of subjects: 60

Group type: COMPARATOR
Intervention: Obturator nerve block
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sham nerve block
Number of subjects: 60
Study: 15104826

Group type: EXPERIMENTAL
Intervention: Conservative laparoscopic surgery with presacral neurectomy (PSN)
Number of subjects: 141

Group type: COMPARATOR
Intervention: Conservative laparoscopic surgery without presacral neurectomy (group A)
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Both groups (with and without PSN)
Number of subjects: 141
Study: 11488769

Group type: EXPERIMENTAL
Intervention: Metformin therapy
Number of subjects: 272

Group type: COMPARATOR
Intervention: Nonmetformin therapy
Number of subjects: 272
Study: 9754983

Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg once daily for 1 week + NSAID (diclofenac 50 mg bid)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg once daily for 1 week + NSAID (naproxen 250 mg bid)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg once daily for 1 week + NSAID (piroxicam 10 mg om)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Omeprazole 20 mg once daily for 1 week
Number of subjects: 0
Study: 8002121

Group type: EXPERIMENTAL
Intervention: Warm-up, stretching exercises, and massage
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (eccentric exercise only)
Number of subjects: 50
Study: 2959967

Group type: EXPERIMENTAL
Intervention: Calcium dobesilate (2 g daily for 4 weeks)
Number of subjects: 25
Study: 29660953

Group type: EXPERIMENTAL
Intervention: Whole-body vibration (WBV) training
Number of subjects: 28
Study: 27143787

Group type: EXPERIMENTAL
Intervention: Shared canister MDI therapy
Number of subjects: 353

Group type: COMPARATOR
Intervention: Single-patient canister therapy
Number of subjects: 353
Study: 25543218

Group type: COMPARATOR
Intervention: Morphine (1 mg/mL) alone for PCA (Group M)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Morphine (1 mg/mL) combined with dezocine (0.05 mg/mL) at a ratio of 20:1 for PCA (Group MD1)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Morphine (1 mg/mL) combined with dezocine (0.1 mg/mL) at a ratio of 10:1 for PCA (Group MD2)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 60

Group type: COMPARATOR
Intervention: Group M
Number of subjects: 60
Study: 23545914

Group type: EXPERIMENTAL
Intervention: Topical gel with 4% Quassia amara extract
Number of subjects: 60

Group type: COMPARATOR
Intervention: Topical gel with 2% ketoconazole
Number of subjects: 60

Group type: COMPARATOR
Intervention: Topical gel with 1% ciclopiroxolamine
Number of subjects: 60
Study: 17169231

Group type: EXPERIMENTAL
Intervention: Self-collected vaginal-rectal swabs
Number of subjects: 330

Group type: COMPARATOR
Intervention: Clinician-collected vaginal-rectal swabs
Number of subjects: 330
Study: 12829672

Group type: EXPERIMENTAL
Intervention: Motexafin gadolinium (MGd) 5 mg/kg/d
Number of subjects: 401

Group type: COMPARATOR
Intervention: Whole-brain radiation therapy (WBRT) 30 Gy
Number of subjects: 401

Group type: EXPERIMENTAL
Intervention: Motexafin gadolinium (MGd)
Number of subjects: 401
Study: 10626701

Group type: EXPERIMENTAL
Intervention: High-velocity, low-amplitude spinal manipulation plus soft tissue therapy 2 to 3 times in the week before menses for at least 3 cycles
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo treatment with a spring-loaded adjusting instrument wound down for minimum force
Number of subjects: 25
Study: 7555936

Group type: EXPERIMENTAL
Intervention: Omeprazole (n = 45), initial dose of 80 mg followed by 40 mg every eight hours for four days, then oral administration
Number of subjects: 86

Group type: COMPARATOR
Intervention: Ranitidine (n = 41), 50 mg every six hours for 12 to 24 hours, then oral administration
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Omeprazole (n = 45)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Ranitidine (n = 41)
Number of subjects: 86
Study: 2021135

Group type: EXPERIMENTAL
Intervention: Olestra (20 g/d)
Number of subjects: 202

Group type: COMPARATOR
Intervention: Placebo (triglycerides)
Number of subjects: 202
Study: 6129179

Group type: EXPERIMENTAL
Intervention: Thioctic acid (alpha-lipoic acid), 300 mg/day
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 31142465

Group type: EXPERIMENTAL
Intervention: DIMS spectacle lenses (myopic defocus of +3.50 D)
Number of subjects: 183

Group type: COMPARATOR
Intervention: Single vision (SV) spectacle lenses
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: DIMS spectacle lenses
Number of subjects: 183
Study: 30683448

Group type: EXPERIMENTAL
Intervention: Total Mastectomy (TM)
Number of subjects: 399

Group type: COMPARATOR
Intervention: Skin-Sparing Mastectomy (SSM)
Number of subjects: 399
Study: 28419193

Group type: EXPERIMENTAL
Intervention: Cabazitaxel
Number of subjects: 70

Group type: COMPARATOR
Intervention: Vinflunine
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 70
Study: 25601342

Group type: EXPERIMENTAL
Intervention: Standard-dose chemoradiotherapy (60 Gy)
Number of subjects: 614

Group type: EXPERIMENTAL
Intervention: High-dose chemoradiotherapy (74 Gy)
Number of subjects: 614

Group type: EXPERIMENTAL
Intervention: Cetuximab with standard-dose chemoradiotherapy (60 Gy)
Number of subjects: 614

Group type: COMPARATOR
Intervention: No cetuximab with standard-dose chemoradiotherapy (60 Gy)
Number of subjects: 614

Group type: EXPERIMENTAL
Intervention: High-dose chemoradiotherapy with cetuximab (74 Gy)
Number of subjects: 614
Study: 23784615

Group type: EXPERIMENTAL
Intervention: Epoetin alfa (60,000 IU administered intravenously within 3 hours after PCI)
Number of subjects: 529

Group type: COMPARATOR
Intervention: Standard optimal medical treatment
Number of subjects: 529
Study: 21315654

Group type: EXPERIMENTAL
Intervention: 5 mg preladenant
Number of subjects: 253

Group type: EXPERIMENTAL
Intervention: 10 mg preladenant
Number of subjects: 253

Group type: EXPERIMENTAL
Intervention: 1 mg preladenant
Number of subjects: 253

Group type: EXPERIMENTAL
Intervention: 2 mg preladenant
Number of subjects: 253

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 253
Study: 19231249

Group type: EXPERIMENTAL
Intervention: Restricted group (RG) received 1500ml of fluids per day
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard group (SG) received 2500ml of fluids per day
Number of subjects: 40
Study: 16310713

Group type: EXPERIMENTAL
Intervention: 0.5 mg/kg oral morphine sulphate
Number of subjects: 34

Group type: COMPARATOR
Intervention: 0.33 mg/kg oral active placebo (diphenhydramine)
Number of subjects: 34
Study: 15593357

Group type: EXPERIMENTAL
Intervention: Revised versions of the Childhood Health Assessment Questionnaire (CHAQ)
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Revised versions of the Childhood Health Assessment Questionnaire (CHAQ) with 8 added items
Number of subjects: 149
Study: 11124360

Group type: EXPERIMENTAL
Intervention: 20 microg ethinylestradiol and 150 microg desogestrel
Number of subjects: 342

Group type: COMPARATOR
Intervention: 30 microg ethinylestradiol and 75 microg gestodene
Number of subjects: 342

Group type: EXPERIMENTAL
Intervention: desogestrel
Number of subjects: 342

Group type: COMPARATOR
Intervention: gestodene
Number of subjects: 342

Group type: EXPERIMENTAL
Intervention: both preparations
Number of subjects: 342
Study: 9286937

Group type: EXPERIMENTAL
Intervention: Aspirin (320 mg/d)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Indobufen (200 mg BID)
Number of subjects: 20
Study: 8420237

Group type: EXPERIMENTAL
Intervention: Overdrive pacing
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Electrical cardioversion (up to two 50 J shocks, then 200 J if unsuccessful)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group (not explicitly defined)
Number of subjects: 22
Study: 3829582

Group type: EXPERIMENTAL
Intervention: verapamil
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: tiapamil
Number of subjects: 16

Group type: COMPARATOR
Intervention: digoxin
Number of subjects: 16

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 16
Study: 29861800

Group type: EXPERIMENTAL
Intervention: Traditional physiotherapy-Mulligan mobilization (TPMM) group
Number of subjects: 42

Group type: COMPARATOR
Intervention: Traditional physiotherapy (TP) group
Number of subjects: 42
Study: 26696645

Group type: EXPERIMENTAL
Intervention: Hypothermia group (standard medical treatment plus endovascular hypothermia with a target temperature of 33 or 34°C for a minimum of 24 hours)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control group (standard medical treatment only with a target temperature of normothermia)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Hypothermia group
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 33
Study: 24929428

Group type: EXPERIMENTAL
Intervention: Low-glycemic-load diet with ALA and MUFA (canola oil-enriched bread supplement, 31 g canola oil per 2,000 kcal)
Number of subjects: 141

Group type: COMPARATOR
Intervention: Whole-grain diet with whole-wheat bread supplement (control)
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Low-glycemic-load diet with ALA and MUFA (canola oil-enriched bread supplement)
Number of subjects: 141
Study: 22082021

Group type: EXPERIMENTAL
Intervention: Cold application prior to chest tube removal
Number of subjects: 140

Group type: COMPARATOR
Intervention: Control group (no cold application)
Number of subjects: 140
Study: 20798629

Group type: EXPERIMENTAL
Intervention: Periareolar de‐epithelialization to a depth of superficial layer of the dermis (Group A)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Periareolar de‐epithelialization nearly to the full thickness of the dermis (Group B)
Number of subjects: 60
Study: 18949043

Group type: EXPERIMENTAL
Intervention: Illusory figure presentation (notch mode)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Real grey squares with inward-oriented notches
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Real grey squares with outward-oriented notches
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control figure (removal of outward-oriented notches)
Number of subjects: 0
Study: 17235682

Group type: EXPERIMENTAL
Intervention: Catheter ablation of AF in DM patients
Number of subjects: 31

Group type: COMPARATOR
Intervention: Catheter ablation of AF in no-DM patients
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Diabetes mellitus as a risk factor
Number of subjects: 31
Study: 12808702

Group type: EXPERIMENTAL
Intervention: PFME therapy with health education program
Number of subjects: 129

Group type: COMPARATOR
Intervention: PFME therapy alone
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: PFME therapy
Number of subjects: 129
Study: 11057405

Group type: EXPERIMENTAL
Intervention: Rhenium-188 (Re-188)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Rhenium-186 (Re-186)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Strontium-89 (Sr-89)
Number of subjects: 44
Study: 8869311

Group type: EXPERIMENTAL
Intervention: Standard 18-G Teflon cannula, removed on completion of infusion, rotated to contralateral arm daily (Group 1)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Similar catheter sited in each forearm, rotation of side of infusion daily (Group 2)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 15-cm Silastic rubber catheter in one forearm and standard cannula in contralateral forearm, alternation of infusion daily (Group 3)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Fine-bore 23-G silicone catheter sited in one arm only, fed continuously over 24 hours (Group 4)
Number of subjects: 60
Study: 1505607

Group type: EXPERIMENTAL
Intervention: Nicardipine 60 mg/day, in three spaced doses for one month
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 6354586

Group type: EXPERIMENTAL
Intervention: PEEP from demand valve system
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: PEEP from high gas flow reservoir bag system
Number of subjects: 24

Group type: COMPARATOR
Intervention: PEEP levels delivered by either system
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Breathing patterns of intubated patients about to be extubated
Number of subjects: 24
Study: 30964562

Group type: EXPERIMENTAL
Intervention: DHE using sign language by the investigator (School A)
Number of subjects: 178

Group type: COMPARATOR
Intervention: DHE by conventional visual method (School B)
Number of subjects: 178
Study: 28246884

Group type: EXPERIMENTAL
Intervention: Patient-centered post-fracture care program with a dedicated case manager
Number of subjects: 436

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 436
Study: 26939716

Group type: EXPERIMENTAL
Intervention: Parent-Infant Psychotherapy (PIP)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Control condition of standard secondary and specialist primary care treatment
Number of subjects: 76
Study: 25138079

Group type: COMPARATOR
Intervention: Intraoperative radiation therapy (IOERT) using electrons
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: External beam radiation therapy (EBRT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intraoperative radiation therapy (IORT) using 50-kV X-rays
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low-risk ELIOT group
Number of subjects: 0
Study: 22449837

Group type: EXPERIMENTAL
Intervention: Pamphlet
Number of subjects: 1314

Group type: COMPARATOR
Intervention: No Pamphlet (Control)
Number of subjects: 1314
Study: 19302674

Group type: EXPERIMENTAL
Intervention: Iris recognition software
Number of subjects: 52

Group type: COMPARATOR
Intervention: No iris recognition software
Number of subjects: 52
Study: 17309330

Group type: EXPERIMENTAL
Intervention: Cervarix vaccine (bivalent L1 virus-like particle vaccine against HPV types 16 and 18)
Number of subjects: 470000
Study: 14678344

Group type: EXPERIMENTAL
Intervention: Intervention group (individualized feedback letters)
Number of subjects: 303

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 303

Group type: EXPERIMENTAL
Intervention: Pages providing references to scientific publications or prescribing information
Number of subjects: 303